184 related articles for article (PubMed ID: 37847239)
1. SOX10 Loss Sensitizes Melanoma Cells to Cytokine-Mediated Inflammatory Cell Death.
Rosenbaum SR; Caksa S; Stefanski CD; Trachtenberg IV; Wilson HP; Wilski NA; Ott CA; Purwin TJ; Haj JI; Pomante D; Kotas D; Chervoneva I; Capparelli C; Aplin AE
Mol Cancer Res; 2024 Feb; 22(2):209-220. PubMed ID: 37847239
[TBL] [Abstract][Full Text] [Related]
2. Sox10 regulates skin melanocyte proliferation by activating the DNA replication licensing factor MCM5.
Su Z; Zheng X; Zhang X; Wang Y; Zhu S; Lu F; Qu J; Hou L
J Dermatol Sci; 2017 Mar; 85(3):216-225. PubMed ID: 27955842
[TBL] [Abstract][Full Text] [Related]
3. Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanoma.
Capparelli C; Purwin TJ; Glasheen M; Caksa S; Tiago M; Wilski N; Pomante D; Rosenbaum S; Nguyen MQ; Cai W; Franco-Barraza J; Zheng R; Kumar G; Chervoneva I; Shimada A; Rebecca VW; Snook AE; Hookim K; Xu X; Cukierman E; Herlyn M; Aplin AE
Nat Commun; 2022 Mar; 13(1):1381. PubMed ID: 35296667
[TBL] [Abstract][Full Text] [Related]
4. The myelin protein PMP2 is regulated by SOX10 and drives melanoma cell invasion.
Graf SA; Heppt MV; Wessely A; Krebs S; Kammerbauer C; Hornig E; Strieder A; Blum H; Bosserhoff AK; Berking C
Pigment Cell Melanoma Res; 2019 May; 32(3):424-434. PubMed ID: 30506895
[TBL] [Abstract][Full Text] [Related]
5. SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effects.
Rosenbaum SR; Tiago M; Caksa S; Capparelli C; Purwin TJ; Kumar G; Glasheen M; Pomante D; Kotas D; Chervoneva I; Aplin AE
Cell Rep; 2021 Dec; 37(10):110085. PubMed ID: 34879275
[TBL] [Abstract][Full Text] [Related]
6. Sox10 is expressed in primary melanocytic neoplasms of various histologies but not in fibrohistiocytic proliferations and histiocytoses.
Shin J; Vincent JG; Cuda JD; Xu H; Kang S; Kim J; Taube JM
J Am Acad Dermatol; 2012 Oct; 67(4):717-26. PubMed ID: 22325460
[TBL] [Abstract][Full Text] [Related]
7. SOX10 Inhibits T Cell Recognition by Inducing Expression of the Immune Checkpoint Molecule PD-L1 in A375 Melanoma Cells.
Sasaki K; Hirohashi Y; Murata K; Minowa T; Nakatsugawa M; Murai A; Mizue Y; Kubo T; Kanaseki T; Tsukahara T; Iwabuchi S; Hashimoto S; Uhara H; Ishida-Yamamoto A; Torigoe T
Anticancer Res; 2023 Apr; 43(4):1477-1484. PubMed ID: 36974807
[TBL] [Abstract][Full Text] [Related]
8. Regulation of SOX10 stability via ubiquitination-mediated degradation by Fbxw7α modulates melanoma cell migration.
Lv XB; Wu W; Tang X; Wu Y; Zhu Y; Liu Y; Cui X; Chu J; Hu P; Li J; Guo Q; Cai Z; Wu J; Hu K; Ouyang N
Oncotarget; 2015 Nov; 6(34):36370-82. PubMed ID: 26461473
[TBL] [Abstract][Full Text] [Related]
9. Sox10 promotes the formation and maintenance of giant congenital naevi and melanoma.
Shakhova O; Zingg D; Schaefer SM; Hari L; Civenni G; Blunschi J; Claudinot S; Okoniewski M; Beermann F; Mihic-Probst D; Moch H; Wegner M; Dummer R; Barrandon Y; Cinelli P; Sommer L
Nat Cell Biol; 2012 Aug; 14(8):882-90. PubMed ID: 22772081
[TBL] [Abstract][Full Text] [Related]
10. SOX10 Regulates Melanoma Immunogenicity through an IRF4-IRF1 Axis.
Yokoyama S; Takahashi A; Kikuchi R; Nishibu S; Lo JA; Hejna M; Moon WM; Kato S; Zhou Y; Hodi FS; Song JS; Sakurai H; Fisher DE; Hayakawa Y
Cancer Res; 2021 Dec; 81(24):6131-6141. PubMed ID: 34728538
[TBL] [Abstract][Full Text] [Related]
11. DNA promoter hypermethylation of melanocyte lineage genes determines melanoma phenotype.
Sanna A; Phung B; Mitra S; Lauss M; Choi J; Zhang T; Njauw CN; Cordero E; Harbst K; Rosengren F; Cabrita R; Johansson I; Isaksson K; Ingvar C; Carneiro A; Brown K; Tsao H; Andersson M; Pietras K; Jönsson G
JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36040798
[TBL] [Abstract][Full Text] [Related]
12. SOX10 ablation arrests cell cycle, induces senescence, and suppresses melanomagenesis.
Cronin JC; Watkins-Chow DE; Incao A; Hasskamp JH; Schönewolf N; Aoude LG; Hayward NK; Bastian BC; Dummer R; Loftus SK; Pavan WJ
Cancer Res; 2013 Sep; 73(18):5709-18. PubMed ID: 23913827
[TBL] [Abstract][Full Text] [Related]
13. SOX10 is as specific as S100 protein in detecting metastases of melanoma in lymph nodes and is recommended for sentinel lymph node assessment.
Szumera-Ciećkiewicz A; Bosisio F; Teterycz P; Antoranz A; Delogu F; Koljenović S; van de Wiel BA; Blokx W; van Kempen LC; Rutkowski P; Christopher van Akkooi A; Cook M; Massi D;
Eur J Cancer; 2020 Sep; 137():175-182. PubMed ID: 32781392
[TBL] [Abstract][Full Text] [Related]
14. ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma.
Han S; Ren Y; He W; Liu H; Zhi Z; Zhu X; Yang T; Rong Y; Ma B; Purwin TJ; Ouyang Z; Li C; Wang X; Wang X; Yang H; Zheng Y; Aplin AE; Liu J; Shao Y
Nat Commun; 2018 Jan; 9(1):28. PubMed ID: 29295999
[TBL] [Abstract][Full Text] [Related]
15. SOX9 is a dose-dependent metastatic fate determinant in melanoma.
Yang X; Liang R; Liu C; Liu JA; Cheung MPL; Liu X; Man OY; Guan XY; Lung HL; Cheung M
J Exp Clin Cancer Res; 2019 Jan; 38(1):17. PubMed ID: 30642390
[TBL] [Abstract][Full Text] [Related]
16. SOX10 expression in superficial spreading and nodular malignant melanomas.
Agnarsdóttir M; Sooman L; Bolander A; Strömberg S; Rexhepaj E; Bergqvist M; Ponten F; Gallagher W; Lennartsson J; Ekman S; Uhlen M; Hedstrand H
Melanoma Res; 2010 Dec; 20(6):468-78. PubMed ID: 20890226
[TBL] [Abstract][Full Text] [Related]
17. Sox10 controls migration of B16F10 melanoma cells through multiple regulatory target genes.
Seong I; Min HJ; Lee JH; Yeo CY; Kang DM; Oh ES; Hwang ES; Kim J
PLoS One; 2012; 7(2):e31477. PubMed ID: 22363655
[TBL] [Abstract][Full Text] [Related]
18. SOX10 promotes melanoma cell invasion by regulating melanoma inhibitory activity.
Graf SA; Busch C; Bosserhoff AK; Besch R; Berking C
J Invest Dermatol; 2014 Aug; 134(8):2212-2220. PubMed ID: 24608986
[TBL] [Abstract][Full Text] [Related]
19. SOX10 immunostaining distinguishes desmoplastic melanoma from excision scar.
Ramos-Herberth FI; Karamchandani J; Kim J; Dadras SS
J Cutan Pathol; 2010 Sep; 37(9):944-52. PubMed ID: 20653825
[TBL] [Abstract][Full Text] [Related]
20. Identification and functional analysis of SOX10 phosphorylation sites in melanoma.
Cronin JC; Loftus SK; Baxter LL; Swatkoski S; Gucek M; Pavan WJ
PLoS One; 2018; 13(1):e0190834. PubMed ID: 29315345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
